Skip to main content
. 2021 Apr 8;5(2):447–455. doi: 10.1016/j.mayocpiqo.2021.02.005

Figure.

Figure

N-terminal pro–B type natriuretic peptide (NT-proBNP) levels trended over time by atrial fibrillation (Afib) status for patients with heart failure with reduced ejection fraction in the Guiding Evidence-Based Therapy Using Biomarker-Intensified Treatment in Heart Failure (GUIDE-IT) trial. Data are trended at 0, 3, 6, 12, and 24 months.